Early initiation of endovascular stroke treatment is critical to give patients the best chance of achieving functional independence, say the HERMES collaborators.

Nonstatin therapies that act via upregulation of the low-density lipoprotein receptor prevent major vascular events as effectively as statins do, shows an analysis in JAMA.

Therapeutic coma should be reserved for severe refractory convulsive status epilepticus after adequate and early dosing of first- and second-line drugs in line with current recommendations, say researchers.

A phase II trial of single-agent dalantercept in patients with platinum-refractory, recurrent or metastatic squamous cell carcinoma of the head and neck has failed to meet its primary efficacy endpoint, a US research team reports.

Chronic liver disease severity and pretreatment α-fetoprotein levels could help to identify hepatocellular carcinoma patients who may benefit from second-line treatment with ramucirumab, suggests an exploratory analysis of the REACH trial.

Post-treatment minimal residual disease status can serve as a marker of long-term survival in patients with newly diagnosed multiple myeloma, shows a meta-analysis.

medwireNews brings you coverage of the 2015 European Cancer Congress, held in Vienna, Austria.

Click through to read the full reports of the latest research.

Visit our dedicated microsite for research news, interviews and in-depth analysis of paediatric endocrinology and growth disorders.

Highlights from the 1st conference of the European Academy of Neurology in Berlin, Germany.

Click through to read research news from the conference.